Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27169563 | 0.77 | — | — | |
| SCHEMBL21496369 | 0.73 | — | — | |
| SCHEMBL2953440 | 0.71 | CYP1A2 (0.30) | CYP1A2MAPK1 | |
| SCHEMBL3453693 | 0.71 | — | — | |
| SCHEMBL7033913 | 0.70 | — | — | |
| SCHEMBL2112762 | 0.67 | — | — | |
| SCHEMBL8191873 | 0.65 | — | — | |
| SCHEMBL1060664 | 0.62 | — | — | |
| SCHEMBL634590 | 0.62 | — | — | |
| SCHEMBL634589 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2419478-B1 | FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES | LI COR INC (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-2630196-B1 | CYANINE DYES AND THEIR CONJUGATES | LI COR INC (US) | 2017-09-06 | — | — | EP | disclosed |
| US-9408924-B2 | Bioconjugates of cyanine dyes | LI-COR, INC. (US) | 2016-08-09 | — | — | US | disclosed |
| US-20150119553-A1 | BIOCONJUGATES OF CYANINE DYES | LI-COR, INC. | 2015-04-30 | — | — | US | disclosed |
| US-8927719-B2 | Cyanine dyes and their conjugates | LI-COR, INC. (US) | 2015-01-06 | — | — | US | disclosed |
| US-20130274452-A1 | CYANINE DYES AND THEIR CONJUGATES | MIDCAP FINANCIAL TRUST | 2013-10-17 | — | — | US | disclosed |
| EP-2630196-A1 | CYANINE DYES AND THEIR CONJUGATES | LI-COR, INC. (US) | 2013-08-28 | — | — | EP | disclosed |
| US-8481752-B2 | Fluorescent imaging with substituted cyanine dyes | LI-COR, INC. (US) | 2013-07-09 | — | — | US | disclosed |
| WO-2012054749-A1 | CYANINE DYES AND THEIR CONJUGATES | LI-COR, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| EP-2419478-A2 | FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES | LI-COR, INC. (US) | 2012-02-22 | — | — | EP | disclosed |
| US-20100323389-A1 | FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES | LI-COR, INC. (US) | 2010-12-23 | — | — | US | disclosed |
| WO-2010121163-A2 | FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES | LI-COR, INC. (US) | 2010-10-21 | — | — | WO | disclosed |
| EP-1019887-B1 | FLUORESCENT CYANINE DYES | LI COR INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6027709-A | BENZO(E)INDOLE-BASED DYES USEFUL AS REPORTER GROUPS FOR LABELING BIOMOECULES; SOLUBILITY RETAINED BY BIOMOLECULE; ATTACHMENT TO DNA, NUCLEOTIDES, PEPTIDES, HORMONES, ENZYMES ETC.; LASER ACTIVATION | LI-COR INC. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5179200-A | N4-(3-PHENYLPROPRIONYL)-2'-DEOXYCYTIDINE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1993-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274452-A1 | CYANINE DYES AND THEIR CONJUGATES | FCGR3B, QPCT, TIE1 | CYP1A2 1397/4885MAPK1 2259/4885 |
| US-20100323389-A1 | FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES | MSR1, TIE1, ALG1 | CYP1A2 1991/4885MAPK1 2847/4885 |
| US-20150119553-A1 | BIOCONJUGATES OF CYANINE DYES | FCGR3B, FCGR2A, HCCS | CYP1A2 515/4885MAPK1 4120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.